Eurofins Scientific SE
ERF
Clasificación en acciones
#1379
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Precio por acción
$93.33
Última sincronización: 2026-10-20
Capitalización bursátil
$16.20B
Cambio (1 día)
-0.33%
Cambio (1 año)
28.73%
País
LU
Comercio Eurofins Scientific SE (ERF)
Categoría
Healthcare
Ratio P/E de Eurofins Scientific SE (ERF)
Ratio P/E al October 2026 TTM: 25.95
Según los últimos informes financieros y el precio de las acciones de Eurofins Scientific SE, el P/E actual (TTM) de la empresa es 25.95. Al final de 2024, la empresa tenía un P/E de 23.13.
Historial del ratio P/E de Eurofins Scientific SE desde 2002 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 25.95 | 9.74% |
| 2025 | 23.65 | 2.25% |
| 2024 | 23.13 | -36.93% |
| 2023 | 36.67 | 73.31% |
| 2022 | 21.16 | -20.54% |
| 2021 | 26.62 | 12.38% |
| 2020 | 23.69 | -47.43% |
| 2019 | 45.07 | 74.87% |
| 2018 | 25.77 | -36.00% |
| 2017 | 40.27 | 8.19% |
| 2016 | 37.22 | -33.98% |
| 2015 | 56.37 | 38.99% |
| 2014 | 40.56 | -0.63% |
| 2013 | 40.82 | 50.69% |
| 2012 | 27.09 | 86.10% |
| 2011 | 14.55 | -55.58% |
| 2010 | 32.76 | -168.24% |
| 2009 | -48.01 | -270.41% |
| 2008 | 28.17 | -55.04% |
| 2007 | 62.67 | 45.55% |
| 2006 | 43.06 | 3.50% |
| 2005 | 41.60 | 44.58% |
| 2004 | 28.77 | -65.77% |
| 2003 | 84.05 | -92.15% |
| 2002 | 1.07K | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 36.15 | 39.31% |
US
|
|
| 39.77 | 53.25% |
US
|
|
| -290.26 | -1,218.38% |
US
|
|
| - | - |
CN
|
|
| 34.18 | 31.72% |
US
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.